Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded revision: v3.4.2; removed the funding-status notice and the prior revision: v3.4.1.SummaryDifference0.4%

- Check78 days agoChange DetectedA site-wide notice about government funding status and a version update (v3.4.1) were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedMinor UI/text updates: a 'Show glossary' option is displayed, the QC-related label is updated (Last Update Submitted that Met QC Criteria), and the revision is updated to v3.4.0 with capitalization tweaks for 'No FEAR Act Data'.SummaryDifference0.2%

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.